Literature DB >> 31377680

Wnt signaling: implications in endoderm development and pancreas organogenesis.

Katharina Scheibner1, Mostafa Bakhti2, Aimée Bastidas-Ponce1, Heiko Lickert3.   

Abstract

The pancreas is derived from the foregut endoderm during embryonic development. After gastrulation and endoderm germ layer formation complex morphogenetic events coupled with cell differentiation programs pattern the gut tube and induce pancreas organogenesis. This results in formation of exocrine, ductal and hormone-producing endocrine cells. Among these, endocrine cells are responsible for blood glucose homeostasis and their malfunction leads to diabetes mellitus, which cannot be stopped or reversed by the current standard treatments. Thus, intense efforts to regenerate or replace the lost or dysfunctional insulin-producing β-cells are on the way. This depends on identifying the factors that coordinate pancreas organogenesis. Here, we highlight the contribution of canonical and non-canonical Wnt signaling branches in orchestrating endoderm formation, pancreatic morphogenesis as well as endocrine cell formation and function.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 31377680     DOI: 10.1016/j.ceb.2019.07.002

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  10 in total

Review 1.  Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer.

Authors:  Xiaojia Li; Jie He; Keping Xie
Journal:  Cell Oncol (Dordr)       Date:  2022-03-15       Impact factor: 6.730

Review 2.  Transcription factor GLIS3: Critical roles in thyroid hormone biosynthesis, hypothyroidism, pancreatic beta cells and diabetes.

Authors:  David W Scoville; Hong Soon Kang; Anton M Jetten
Journal:  Pharmacol Ther       Date:  2020-07-18       Impact factor: 12.310

Review 3.  Molecular prospect of type-2 diabetes: Nanotechnology based diagnostics and therapeutic intervention.

Authors:  Rout George Kerry; Gyana Prakash Mahapatra; Ganesh Kumar Maurya; Sushmita Patra; Subhasis Mahari; Gitishree Das; Jayanta Kumar Patra; Sabuj Sahoo
Journal:  Rev Endocr Metab Disord       Date:  2020-10-14       Impact factor: 6.514

4.  Identification of the Shared Gene Signatures and Biological Mechanism in Type 2 Diabetes and Pancreatic Cancer.

Authors:  Yifang Hu; Ni Zeng; Yaoqi Ge; Dan Wang; Xiaoxuan Qin; Wensong Zhang; Feng Jiang; Yun Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555

5.  Chronically Elevated Exogenous Glucose Elicits Antipodal Effects on the Proteome Signature of Differentiating Human iPSC-Derived Pancreatic Progenitors.

Authors:  Luiza Ghila; Thomas Aga Legøy; Andreas Frøslev Mathisen; Shadab Abadpour; Joao A Paulo; Hanne Scholz; Helge Ræder; Simona Chera
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

Review 6.  Harnessing the Power of Stem Cell Models to Study Shared Genetic Variants in Congenital Heart Diseases and Neurodevelopmental Disorders.

Authors:  Xuyao Chang; Mingxia Gu; Jason Tchieu
Journal:  Cells       Date:  2022-01-28       Impact factor: 6.600

Review 7.  Maturation of beta cells: lessons from in vivo and in vitro models.

Authors:  Tom Barsby; Timo Otonkoski
Journal:  Diabetologia       Date:  2022-03-04       Impact factor: 10.460

Review 8.  Hippo Signaling Pathway in Pancreas Development.

Authors:  Yifan Wu; Pauline Aegerter; Michael Nipper; Logan Ramjit; Jun Liu; Pei Wang
Journal:  Front Cell Dev Biol       Date:  2021-05-17

Review 9.  β-Cell Maturation and Identity in Health and Disease.

Authors:  Ciro Salinno; Perla Cota; Aimée Bastidas-Ponce; Marta Tarquis-Medina; Heiko Lickert; Mostafa Bakhti
Journal:  Int J Mol Sci       Date:  2019-10-30       Impact factor: 5.923

Review 10.  Current strategies and opportunities to manufacture cells for modeling human lungs.

Authors:  Ratna Varma; John P Soleas; Thomas K Waddell; Golnaz Karoubi; Alison P McGuigan
Journal:  Adv Drug Deliv Rev       Date:  2020-08-22       Impact factor: 15.470

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.